BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28219001)

  • 21. Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma.
    Cho H; Kim SH; Kim SJ; Chang JH; Yang WI; Suh CO; Kim YR; Jang JE; Cheong JW; Min YH; Kim JS
    Oncotarget; 2017 Oct; 8(50):87317-87328. PubMed ID: 29152083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and prognostic significance of microenvironment related prognostic factors in patients with classical Hodgkin's lymphoma].
    Wang TT; Li SX; Xia B; Zhao HF; Xu W; Yang HL; Wang XF; Yu Y; Sun BC; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(18):1400-1405. PubMed ID: 28535626
    [No Abstract]   [Full Text] [Related]  

  • 23. MGCD0103 induces apoptosis and simultaneously increases the expression of NF-κB and PD-L1 in classical Hodgkin's lymphoma.
    Huang R; Zhang X; Min Z; Shadia AS; Yang S; Liu X
    Exp Ther Med; 2018 Nov; 16(5):3827-3834. PubMed ID: 30344659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and prognostic value of PD-L1 and PD-L2 in ovarian cancer.
    Xue C; Zhu D; Chen L; Xu Y; Xu B; Zhang D; Jiang J
    Transl Cancer Res; 2019 Feb; 8(1):111-119. PubMed ID: 35116740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Significance of Immune-checkpoint Molecule PD-L1 in Classical Hodgkin Lymphoma: A Clinicopathologic Study of 120 Cases.
    Kubes V; Kren L; Sokol F; Michalka J; Muzik J; Arpas T; Krenova Z; Kral Z
    In Vivo; 2023; 37(4):1735-1742. PubMed ID: 37369476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Checkpoint CD47 expression in classical Hodgkin lymphoma.
    Gholiha AR; Hollander P; Löf L; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini RM; Enblad G
    Br J Haematol; 2022 Jun; 197(5):580-589. PubMed ID: 35301709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma.
    Miyake M; Oda Y; Nishimura N; Morizawa Y; Ohnishi S; Hatakeyama K; Fujii T; Hori S; Gotoh D; Nakai Y; Anai S; Torimoto K; Tsukamoto S; Fujii H; Kido A; Honoki K; Matsumura Y; Okajima E; Tanaka N; Fujimoto K
    Oncol Lett; 2020 Nov; 20(5):190. PubMed ID: 32952659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications.
    Wolkow N; Jakobiec FA; Afrogheh AH; Eagle RC; Pai SI; Faquin WC
    Am J Ophthalmol; 2019 Apr; 200():226-241. PubMed ID: 30633894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.
    Wha Koh Y; Park C; Hyun Yoon D; Suh C; Huh J
    Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
    Jiao Q; Liu C; Li W; Li W; Fang F; Qian Q; Zhang X
    Clin Exp Immunol; 2017 Jun; 188(3):420-429. PubMed ID: 28052400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
    Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
    Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance.
    Muhamad H; Suksawai N; Assanasen T; Polprasert C; Bunworasate U; Wudhikarn K
    Acta Haematol; 2020; 143(1):78-88. PubMed ID: 31330525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
    Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
    Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and significance of programmed cell death ligand-1 in neuroblastoma tissues].
    Liao R; Sun XF; Zhen ZZ; Huang DS
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):735-740. PubMed ID: 30293276
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
    Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
    Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma.
    Matsubara T; Takada K; Azuma K; Takamori S; Toyokawa G; Haro A; Osoegawa A; Tagawa T; Kawahara A; Akiba J; Okamoto I; Nakanishi Y; Oda Y; Hoshino T; Maehara Y
    Ann Surg Oncol; 2019 Jun; 26(6):1925-1933. PubMed ID: 30815803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1 Immunohistochemistry Highlights Bone Marrow Involvement by Classic Hodgkin Lymphoma in Staging Biopsies: Implications for Diagnosis and Tumor Microenvironment Alterations.
    Xing W; Mai N; Dresser K; Chen BJ
    Appl Immunohistochem Mol Morphol; 2019; 27(5):356-363. PubMed ID: 29271790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
    Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
    Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of PD-L1 and PD-L2 overexpression in patients with esophageal squamous cell carcinoma.
    Hsieh CC; Hsu HS; Li AF; Chen YJ
    J Thorac Dis; 2018 Jul; 10(7):4433-4444. PubMed ID: 30174892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.